Uroepithelial carcinoma is a malignant tumor originating from the epithelium of the urinary tract, which is prevalent in the elderly, and the most common type is bladder cancer, which is overall more serious.
Uroepithelial carcinoma is histologically classified as high-grade, characterized by rapid growth and poor differentiation. Even if the growth is non-invasive, it may invade into deeper tissues and metastasize, so it needs extra attention and should be treated as early as possible and standardized treatment plan should be formulated.
For the treatment of uroepithelial carcinoma, it is necessary to combine the differentiation degree of the tumor, the clinical stage and the patient’s systemic condition to formulate appropriate treatment modalities, with surgery as the main treatment. In addition, due to the high recurrence rate of this tumor, it needs to be supplemented with radiotherapy or immunotherapy after surgery.